Showing results (551-560 of 1,361) with videos related to

Sort By:
Pageof 137
Cancer Research|March 9, 2005
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivityJinjiang Dong, Junying Peng, Haixia Zhang, et al.
Proteome Science|September 26, 2012
An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arraysHuifang Guo, Wenbin Liu, Zhenlin Ju, et al.
Cancer Research|July 17, 2001
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cellsI Braunstein, O Cohen-Barak, C Shachaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumorsYi Chen, Natalia Guggisberg, Merce Jorda, et al.
AIDS (London, England)|August 1, 1993
Splenectomy in patients with AIDS and AIDS-related complexM M Kemeny, V Cooke, T S Melester, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2017
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrenceKatherine C Kurnit, Grace N Kim, Bryan M Fellman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosisF J Xu, S Stack, C Boyer, et al.
British Journal of Cancer|May 5, 2005
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cellsM Mandal, S Kim, M N Younes, et al.
Science Advances|October 3, 2020
Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and responseYaron Vinik, Francisco Gabriel Ortega, Gordon B Mills, et al.
Cancer Research|November 29, 2018
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAnessJianfeng Shen, Wei Zhao, Zhenlin Ju, et al.
Pageof 137